About: A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 28 May 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в травні 2009 (uk) scientific article published on 28 May 2009 (en) مقالة علمية نشرت في 28 مايو 2009 (ar)
publication date	wds:Q37304782-AB397D23-6570-4063-AA2F-B6229F55D533
publication date	2009-05-28 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37304782-75470EDC-831D-4B04-AF18-C09230D27259
language of work or name	English
cites work	wds:Q37304782-080FE6D9-B79E-4140-A974-2D4AC1952441 wds:Q37304782-082A08FB-E6D9-444E-ACD8-79FF5EA82899 wds:Q37304782-0A95B49D-5392-46EC-A776-AB7155296B95 wds:Q37304782-0BB3FF74-7D10-49E7-93EC-AA381D49C81D wds:Q37304782-14BCEF74-EA4B-403B-A19F-E6FDB1DC5E37 wds:Q37304782-16A1F274-28DA-4BCA-A61E-0C4C161C6D84 wds:Q37304782-17888260-272E-4B83-AD6D-459E54C64696 wds:Q37304782-19666D79-1F7A-444F-B51F-4140C07B3924 wds:Q37304782-23F828F2-93F1-40C6-8ADF-5EEABB1E905E wds:Q37304782-2D97279B-61CD-4795-A574-E2318E5E63DF wds:Q37304782-4D47BA27-5740-4D76-886C-7AC663657E5F wds:Q37304782-4ECFCF56-C07A-499E-9FC8-4877BA79A456 wds:Q37304782-547CF2D0-A5E2-40EC-9369-0B6EFF002B7C wds:Q37304782-57CE74A0-DE1B-4525-9BB8-726CC72D2E31 wds:Q37304782-5C3ECD32-B99E-42A8-9185-0D9379AB28EF wds:Q37304782-5C8D7AA3-89CE-4A33-A258-E3A98AA3D387 wds:Q37304782-6432019B-DEF8-4FC4-B9B2-A7FE1C629019 wds:Q37304782-725B93BB-AD1D-4DF4-A81A-E8C11F69A221 wds:Q37304782-727DA170-562D-460E-9D3A-E1A735816EE1 wds:Q37304782-7DEA891F-F21C-489A-A442-CF2644C112AC wds:Q37304782-927DF80B-48C2-4DC4-BE93-523B41F86DF7 wds:Q37304782-95000D9E-7B7E-4E70-92CC-833A689F067C wds:Q37304782-A25AA570-64F2-44CE-8EB0-3EE0FFE44615 wds:Q37304782-AB3637DE-9BE8-416C-8FF5-18769FB5215A wds:Q37304782-AF9CE1CE-D7D9-4251-968C-0827028ED3DA wds:Q37304782-B500227B-B3A3-461F-B57C-25A3D17EFA1E wds:Q37304782-B6FB2136-7E09-41CD-99A5-8D5F0A1A6BAA wds:Q37304782-BF0EC814-9571-4D89-B630-8ADBD2253AEE wds:Q37304782-C266BB41-2315-40AF-AF8F-F0118F7DB7C6 wds:Q37304782-CED74838-3DAC-4A97-AE08-E58D3C959E08 wds:Q37304782-D922E0C9-2CFF-4B18-B3CF-444A787FEB8A wds:Q37304782-E292B0B1-763D-4D48-ABE1-DAFCAF9BFF57 wds:Q37304782-F07A3999-C1C0-40AA-B95B-226A295C791A wds:Q37304782-F76C8B52-78CB-4F09-9DCC-351D297F47CB
cites work	A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years Cannabis abuse and the course of recent-onset schizophrenic disorders Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. A prospective evaluation of adherence to medication in first episode schizophrenia. Role of Ethnicity in Predicting Antipsychotic Medication Adherence Transdermal nicotine alters some of marihuana's effects in male and female volunteers Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects Course of substance misuse and daily tobacco use in first-episode psychosis. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Medication adherence of individuals with a first episode of psychosis Early intervention in psychosis. The critical period hypothesis First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective First-episode non-affective psychosis in a total urban population: a 5-year follow-up Smoking tobacco along with marijuana increases symptoms of cannabis dependence Social class and mental illness: a community study. 1958. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Diagnosis of alcohol use disorders in schizophrenia Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes Substance misuse at presentation to an early psychosis program Impact of an early psychosis program on substance use. First-episode schizophrenia with long duration of untreated psychosis. Pathways to care Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight Clinical correlates of early medication adherence: West London first episode schizophrenia study The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Substance abuse in first-episode non-affective psychosis The Insight-Adherence-Abstinence triad: an integrated treatment focus for cannabis-using first-episode schizophrenia patients.
author name string	wds:Q37304782-0D6C08E7-0580-4903-B87B-23BF59BAF5E0 wds:Q37304782-1CAFD163-CD00-4351-8218-F1F62F12A880 wds:Q37304782-3AC4DCBC-76CB-4EC3-9713-B7290DBD85E0 wds:Q37304782-4B303354-A682-4AC3-9D9D-976F5D1B1B8A wds:Q37304782-F8F3F089-2EA6-4CC2-8B8F-2C0ECA11F7A8
author name string	Rachel Miller Delbert Robinson Serge Sevy Handan Gunduz-Bruce Joanne McCormack
rdfs:label	A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software